Rtw Investments »

4d Molecular Therapeutics In shares owned by Rtw Investments

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Rtw Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.6M 476k 7.50

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Argenx Se Sponsored Adr (ARGX)
Protagonist Therapeutics (PTGX)
Natera (NTRA)
RadNet (RDNT)
Tarsus Pharmaceuticals (TARS)
Cogent Biosciences (COGT)
Penumbra (PEN)
Irhythm Technologies (IRTC)
Apogee Therapeutics (APGE)
Apellis Pharmaceuticals (APLS)
ACADIA Pharmaceuticals (ACAD)
Establishment Labs Holdings Ord (ESTA)

View all positions for Rtw Investments

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In